These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8023469)

  • 1. [Actilyse (a recombinant tissue-type plasminogen activator] in the treatment of acute myocardial infarct. Comparison of the effects of Actilyse and streptokinase].
    Bastecký J; Kvasnicka J; Macek K; Malý J; Rozsíval V; Chrobák L; Gajdosová I; Skopecková H; Wasylivová V; Ettlerová E
    Vnitr Lek; 1994 May; 40(5):293-8. PubMed ID: 8023469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Are the publicized advantages of thrombolytic treatment of myocardial infarct with recombinant t-PA (ACTILYSE) in comparison with streptokinase so decisive, that despite the high cost a general use of ACTILYSE is justified?].
    Gulba DC
    Internist (Berl); 1992 May; 33(5):364-5. PubMed ID: 1612871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of reperfusion and coronary reocclusion on the variability of heart rate in patients with acute myocardial infarction].
    Pizzi C; Costa GM; Borghi A; Premuda G; Tondini C; Magri G; Cordioli E; Bugiardini R
    Cardiologia; 1999 Feb; 44(2):181-6. PubMed ID: 10208055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early evaluation of results from systemic thrombolysis in acute myocardial infarct: the value of troponin I].
    Giraldi F; Grazi S; Guazzi MD
    Cardiologia; 1998 May; 43(5):485-91. PubMed ID: 9701879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolysis, Actilyse, myocardial infarct].
    Mezard-Eurin M
    Rev Infirm; 1988 Sep; 38(14):50-3. PubMed ID: 3143144
    [No Abstract]   [Full Text] [Related]  

  • 13. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of myoglobin for the early diagnosis of reperfusion in acute myocardial infarct].
    Politi A; Galli M; Bonatti R; Zerboni S; Pagani A; Jemoli R; Ferrari G
    Cardiologia; 1994 May; 39(5):303-7. PubMed ID: 8087811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic treatment of acute myocardial infarct].
    Neuhaus KL
    Fortschr Med; 1986 Aug; 104(30):578-82. PubMed ID: 3093344
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative evaluation between streptokinase and r-TPA in limiting the myocardial damage during an acute myocardial infarct. An echocardiographic study].
    Morelloni S; Fasciolo L; Freggiaro V; Corazza M; Pareti G; Davi R; Allegri M
    Clin Ter; 1990 Dec; 135(5):359-65. PubMed ID: 2150366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment.
    Haglund AC; Ronquist G; Frithz G; Ek P
    Thromb Res; 2000 Apr; 98(2):147-56. PubMed ID: 10713316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.